FEops HEARTguide vs HeartFlow Analysis
AI Verdict
Choose FEops HEARTguide if…
Choose FEops HEARTguide if your primary need is to optimize pre-procedural planning for structural heart interventions. This platform is ideal for clinicians seeking predictive simulations and patient-specific digital twins to precisely size and position devices, aiming to improve patient outcomes in complex structural heart cases.
View FEops HEARTguide →Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a non-invasive, AI-powered solution for the diagnosis and management of coronary artery disease. This tool excels at creating personalized 3D models of coronary arteries and providing functional assessments like FFRct and plaque analysis, enabling decisive coronary care without invasive procedures.
View HeartFlow Analysis →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FEops HEARTguide | HeartFlow Analysis |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Cloud Based platform | Cloud-based (AWS) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FEops HEARTguideFEops HEARTguide (Tool A) offers an interactive 2D and 3D viewer with semi-automatic identification and measurement of anatomical landmarks, suggesting a more hands-on and direct user experience for procedure planning. While both are cloud-based, Tool A's features imply greater user control and interaction with the digital twin model.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis (Tool B) provides a non-invasive solution for diagnosing and managing coronary artery disease (CAD), a highly prevalent condition, using validated FFRct and Plaque Analysis. Its high diagnostic accuracy and integration into clinical guidelines, including Class 1 evidence for CCTA and Class 2a for FFRct in chest pain guidelines, demonstrate significant clinical impact on a broad patient population.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis (Tool B) clearly outlines its fee-for-service model, coverage by Medicare and most U.S. commercial payers, and established Category I CPT codes (75580, 75577 for 2026) with CMS payment rates. This transparency and established reimbursement pathway significantly enhance its financial value proposition for healthcare providers, unlike Tool A which only states 'contact for pricing'.
Enterprise Readiness
HeartFlow AnalysisBoth tools are cloud-based, HIPAA compliant, and FDA cleared. However, HeartFlow Analysis (Tool B) explicitly mentions its deployment on AWS and having a Business Associate Agreement (BAA), which provides more specific assurances regarding data security and compliance crucial for enterprise adoption.
Innovation
TieBoth tools demonstrate high levels of innovation in their respective fields. FEops HEARTguide (Tool A) leverages digital twin technology and predictive simulations for personalized structural heart procedure planning, offering unique insights into device-anatomy interaction. HeartFlow Analysis (Tool B) pioneered the non-invasive assessment of coronary artery disease using AI and Computational Fluid Dynamics (CFD) to derive FFRct, a significant advancement in cardiology diagnostics.
Support & Docs
HeartFlow AnalysisWhile both companies offer training and educational resources, HeartFlow (Tool B) provides a more comprehensive and explicitly detailed support structure, including dedicated regional support specialists, billing and reimbursement support, technology integration assistance, and peer-to-peer education. FEops (Tool A) mentions training slide decks and a support email, but lacks the breadth of documented support services.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FEops HEARTguide | HeartFlow Analysis |
|---|---|---|
| Name | FEops HEARTguide | HeartFlow Analysis |
| Company | FEops NV | HeartFlow |
| Description | Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes. | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. |
| Primary Focus | Structural heart procedure planning | Diagnosing and managing coronary artery disease (CAD) |
| Key Technologies | Predictive simulation, AI-based anatomical measurements, Digital twin technology | AI-powered 3D modeling, FFRct analysis, Plaque Analysis, Computational Fluid Dynamics (CFD) |
| Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring FEops HEARTguide and HeartFlow Analysis.